End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.754 RON | -0.26% |
|
+0.53% | +11.70% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 44.43 | 38.51 | 67.71 | 66.44 | 56.16 | 64.25 |
Enterprise Value (EV) 1 | 40.96 | 30.05 | 34.22 | 43.56 | 39.27 | 31.88 |
P/E ratio | 14.6 x | 15.8 x | 1.78 x | 9.21 x | 9.7 x | 8.95 x |
Yield | - | - | 23.4% | 7.16% | 8.47% | 7.41% |
Capitalization / Revenue | 0.1 x | 0.09 x | 0.15 x | 0.14 x | 0.1 x | 0.11 x |
EV / Revenue | 0.09 x | 0.07 x | 0.08 x | 0.09 x | 0.07 x | 0.05 x |
EV / EBITDA | 15.1 x | -58.9 x | 9.95 x | 4.77 x | 3.81 x | 2.73 x |
EV / FCF | -5.37 x | 11.9 x | -14.2 x | 4.22 x | 25.6 x | 1.46 x |
FCF Yield | -18.6% | 8.43% | -7.05% | 23.7% | 3.91% | 68.5% |
Price to Book | 0.95 x | 0.78 x | 0.85 x | 0.97 x | 0.82 x | 0.88 x |
Nbr of stocks (in thousands) | 105,790 | 105,790 | 105,790 | 95,181 | 95,181 | 95,181 |
Reference price 2 | 0.4200 | 0.3640 | 0.6400 | 0.6980 | 0.5900 | 0.6750 |
Announcement Date | 4/25/19 | 4/15/20 | 4/15/21 | 4/20/22 | 4/22/23 | 4/25/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 464 | 446.4 | 441.5 | 477.1 | 535.9 | 593.4 |
EBITDA 1 | 2.72 | -0.5101 | 3.441 | 9.137 | 10.31 | 11.67 |
EBIT 1 | 2.037 | -1.161 | 2.92 | 8.277 | 6.434 | 6.762 |
Operating Margin | 0.44% | -0.26% | 0.66% | 1.73% | 1.2% | 1.14% |
Earnings before Tax (EBT) 1 | 3.683 | 3.123 | 42.77 | 8.633 | 7.058 | 8.909 |
Net income 1 | 3.048 | 2.441 | 37.77 | 7.233 | 5.809 | 7.202 |
Net margin | 0.66% | 0.55% | 8.56% | 1.52% | 1.08% | 1.21% |
EPS 2 | 0.0287 | 0.0230 | 0.3600 | 0.0758 | 0.0608 | 0.0754 |
Free Cash Flow 1 | -7.63 | 2.534 | -2.414 | 10.32 | 1.535 | 21.82 |
FCF margin | -1.64% | 0.57% | -0.55% | 2.16% | 0.29% | 3.68% |
FCF Conversion (EBITDA) | - | - | - | 112.94% | 14.89% | 186.97% |
FCF Conversion (Net income) | - | 103.81% | - | 142.66% | 26.42% | 303.03% |
Dividend per Share | - | - | 0.1500 | 0.0500 | 0.0500 | 0.0500 |
Announcement Date | 4/25/19 | 4/15/20 | 4/15/21 | 4/20/22 | 4/22/23 | 4/25/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 3.47 | 8.46 | 33.5 | 22.9 | 16.9 | 32.4 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -7.63 | 2.53 | -2.41 | 10.3 | 1.54 | 21.8 |
ROE (net income / shareholders' equity) | 6.68% | 5.1% | 58.6% | 9.77% | 8.5% | 10.3% |
ROA (Net income/ Total Assets) | 0.51% | -0.26% | 0.72% | 2.09% | 1.5% | 1.4% |
Assets 1 | 596.4 | -937.1 | 5,224 | 346.4 | 388.1 | 512.9 |
Book Value Per Share 2 | 0.4400 | 0.4600 | 0.7500 | 0.7200 | 0.7200 | 0.7700 |
Cash Flow per Share 2 | 0.0300 | 0.1000 | 0.3200 | 0.2500 | 0.1900 | 0.3700 |
Capex 1 | 0.99 | 0.8 | 0.08 | 0.04 | 0.04 | 1.38 |
Capex / Sales | 0.21% | 0.18% | 0.02% | 0.01% | 0.01% | 0.23% |
Announcement Date | 4/25/19 | 4/15/20 | 4/15/21 | 4/20/22 | 4/22/23 | 4/25/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+11.70% | 15.15M | |
-14.49% | 7.88B | |
+24.12% | 1.33B | |
+8.15% | 278M | |
+8.89% | 223M | |
-47.09% | 79.61M | |
-32.11% | 64.97M | |
+31.90% | 62.64M |
- Stock Market
- Equities
- RMAH Stock
- Financials Farmaceutica REMEDIA S.A.